These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 9312719)

  • 21. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of mu and kappa opioids on injury-induced microglial accumulation in leech CNS: involvement of the nitric oxide pathway.
    Yahyavi-Firouz-Abadi N; Tahsili-Fahadan P; Ostad SN
    Neuroscience; 2007 Feb; 144(3):1075-86. PubMed ID: 17169497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Contribution of the opioid system to realization of inotropic effects of Rhodiola rosea extracts in ischemic and reperfusion heart damage in vitro].
    Lishmanov IuB; Naumova AV; Afanas'ev SA; Maslov LN
    Eksp Klin Farmakol; 1997; 60(3):34-6. PubMed ID: 9324395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of mu opioid receptors in the medial preoptic area following copulation in male rats.
    Coolen LM; Fitzgerald ME; Yu L; Lehman MN
    Neuroscience; 2004; 124(1):11-21. PubMed ID: 14960335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Do endogenous ligands of peripheral mu- and delta-opiate receptors mediate anti-arrhythmic and cardioprotective effects of Rhodiola rosea extract?].
    Maslov LN; Lishmanov IuB; Naumova AV; Lasukova TV
    Biull Eksp Biol Med; 1997 Aug; 124(8):151-3. PubMed ID: 9410196
    [No Abstract]   [Full Text] [Related]  

  • 26. Stress activates endogenous pain-inhibitory systems: opioid and non-opioid mechanisms.
    Lewis JW; Cannon JT; Stapleton JM; Liebeskind JC
    Proc West Pharmacol Soc; 1980; 23():85-8. PubMed ID: 7403170
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of heart contractile disorders in experimental infarct by using preliminary adaptation to stress exposure and opioid peptides].
    Meerson FZ; Dmitriev AD; Zaiats VI
    Kardiologiia; 1984 Sep; 24(9):81-8. PubMed ID: 6542954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of endogenous opioid peptides to secretion of hormones: introductory remarks.
    Meites J
    Fed Proc; 1980 Jun; 39(8):2531-2. PubMed ID: 7380026
    [No Abstract]   [Full Text] [Related]  

  • 29. Endogenous opioid peptides.
    Goedert M; Otten U; Metz H
    Bull Soc Sci Med Grand Duche Luxemb; 1981; 118(1):7-17. PubMed ID: 7318117
    [No Abstract]   [Full Text] [Related]  

  • 30. [Physiologic and molecular mechanisms of action of endogenous opioid peptides].
    Mravian SR
    Patol Fiziol Eksp Ter; 1993; (3):58-60. PubMed ID: 8058416
    [No Abstract]   [Full Text] [Related]  

  • 31. Endogenous opioid mechanism in neuroendocrine regulation in normal and psychopathological states.
    Psychopharmacol Bull; 1982 Jul; 18(3):204-21. PubMed ID: 7146249
    [No Abstract]   [Full Text] [Related]  

  • 32. [The role of the opioid system in body adaptation and protection of the heart in stress].
    Lishmanov IuB; Maslov LN; Lasukova TV
    Usp Fiziol Nauk; 1997; 28(1):75-96. PubMed ID: 9139479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Do endogenous opioid peptides participate in the realization of the cardioprotective effect of adaptation?].
    Lishmanov IuB; Maslov LN; Naryzhnaia NV
    Patol Fiziol Eksp Ter; 1997; (3):3-5. PubMed ID: 9312719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Processes of protein biosynthesis in cardiac muscle and cardioprotective effect of mu-opiate receptor ligands in immobilization stress].
    Naryzhnaia NV; Maslov LN; Lishmanov IuB
    Vopr Med Khim; 2000; 46(2):127-34. PubMed ID: 10885032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Endogenic opioid peptides and antiarrhythmic effect of adaptation to stress].
    Maslov LN; Naryzhnaia NV; Krylatov AV; Gross GJ
    Patol Fiziol Eksp Ter; 2004; (4):11-4. PubMed ID: 15568495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Morphofunctional manifestations of cardioprotective effect of mu-opioid receptor stimulation in stress].
    Maslov LN; Revinskaia IuG; Ryzhov AI; Naryzhnaia NV
    Patol Fiziol Eksp Ter; 2001; (2):8-12. PubMed ID: 11550368
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.